Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands

scientific article

Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2012PLoSO...748807S
P356DOI10.1371/JOURNAL.PONE.0048807
P932PMC publication ID3495962
P698PubMed publication ID23152809
P5875ResearchGate publication ID233419392

P50authorHester E. de MelkerQ88923681
Chris J L M MeijerQ90379336
P2093author name stringFiona R M van der Klis
Guy A M Berbers
Rutger M Schepp
Hein J Boot
Madelief Mollers
Mirte Scherpenisse
P2860cites workHuman papillomavirus is a necessary cause of invasive cervical cancer worldwideQ29617514
Trends in sexually transmitted infections (other than HIV) in older people: analysis of data from an enhanced surveillance systemQ31160831
Second national serum bank for population-based seroprevalence studies in the NetherlandsQ33451887
Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims dataQ33630092
Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infectionQ34089060
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa RicaQ34557325
Clinician's guide to human papillomavirus immunology: knowns and unknownsQ34982885
HPV - immune response to infection and vaccinationQ35180148
Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccinationQ35566274
Time trends in prevalence of cervical cytological abnormality in women attending a sexually transmitted diseases clinic and their relationship to trends in sexual activity and specific infectionsQ36027435
The natural history of cervical HPV infection: unresolved issuesQ36691070
Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study.Q50543183
Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys.Q50601140
Natural history of cervicovaginal papillomavirus infection in young women.Q50909200
Age-specific HPV seroprevalence among young females in The Netherlands.Q51562227
Seroprevalence and Determinants of Eight High-Risk Human Papillomavirus Types in Homosexual Men, Heterosexual Men, and Women: A Population-Based Study in AmsterdamQ58813715
Epidemiology of HPV infection among Mexican women with normal cervical cytologyQ73421792
Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in FinlandQ73683181
Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996Q77526155
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidenceQ78132552
A study of sexuality and health among older adults in the United StatesQ36717888
Genital injuries in postmenopausal women after sexual assaultQ37337777
Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trialQ37622656
Current concepts on human papillomavirus infections in childrenQ37765660
Time trends of human papillomavirus type distribution in Italian women with cervical intraepithelial neoplasia (CIN).Q38420261
Temporal trends over 3 decades and intrafamilial clustering of HPV types in Swedish patients with cervical cancer in situQ38420657
Seroprevalence of human papillomavirus type 16 infection in the United StatesQ39634492
Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008.Q39763457
Disassortative sexual mixing among migrant populations in The Netherlands: a potential for HIV/STI transmission?Q39902894
Absolute risk reductions, relative risks, relative risk reductions, and numbers needed to treat can be obtained from a logistic regression modelQ43512856
Immunosurveillance and the evaluation of national immunization programmes: a population-based approachQ43687132
Seroprevalence of human papillomavirus 6, 11, 16, and 18 in young primiparous women in Sao Paulo, BrazilQ44079424
Seroprevalence of seven high-risk HPV types in The NetherlandsQ44212348
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infectionQ44238190
Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in AustraliaQ44729449
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publicationQ47860026
Stability over time of serum antibody levels to human papillomavirus type 16.Q48023859
Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.Q50179188
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectNetherlandsQ55
seroprevalenceQ3511357
P304page(s)e48807
P577publication date2012-11-12
P1433published inPLOS OneQ564954
P1476titleChanges in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands
P478volume7

Reverse relations

cites work (P2860)
Q36141756A cross-sectional study on the concordance between vaginal HPV DNA detection and type-specific antibodies in a multi-ethnic cohort of women from Amsterdam, the Netherlands - the HELIUS study
Q41201908HPV-vaccination - not just for girls
Q89843473High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands
Q37648087Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013.
Q47425160Prevalence of Human Papillomavirus Genotypes and Abnormal Pap Smears Among Women in the Military Health System.
Q38110696Review: current knowledge on the role of HPV antibodies after natural infection and vaccination: implications for monitoring an HPV vaccination programme
Q36208231Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study

Search more.